SG11201707719WA - Dispersible dosage form - Google Patents

Dispersible dosage form

Info

Publication number
SG11201707719WA
SG11201707719WA SG11201707719WA SG11201707719WA SG11201707719WA SG 11201707719W A SG11201707719W A SG 11201707719WA SG 11201707719W A SG11201707719W A SG 11201707719WA SG 11201707719W A SG11201707719W A SG 11201707719WA SG 11201707719W A SG11201707719W A SG 11201707719WA
Authority
SG
Singapore
Prior art keywords
dosage form
dispersible dosage
dispersible
dosage
Prior art date
Application number
SG11201707719WA
Inventor
Leonie Wagner-Hattler
Maxim Puchkov
Jörg Huwyler
Tanja Stirnimann
Quijano Carolina Diaz
Joachim Schoelkopf
Patrick A C Gane
Daniel E Gerard
Original Assignee
Omya Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omya Int Ag filed Critical Omya Int Ag
Publication of SG11201707719WA publication Critical patent/SG11201707719WA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216Solid or semisolid forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1664Compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2068Compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01FCOMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F11/00Compounds of calcium, strontium, or barium
    • C01F11/18Carbonates
    • C01F11/185After-treatment, e.g. grinding, purification, conversion of crystal morphology
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/10Solid density
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/12Surface area
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/14Pore volume

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Geology (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Seasonings (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Cosmetics (AREA)
SG11201707719WA 2015-03-20 2016-03-15 Dispersible dosage form SG11201707719WA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15160194.5A EP3069713A1 (en) 2015-03-20 2015-03-20 Dispersible dosage form
US201562203948P 2015-08-12 2015-08-12
PCT/EP2016/055590 WO2016150773A1 (en) 2015-03-20 2016-03-15 Dispersible dosage form

Publications (1)

Publication Number Publication Date
SG11201707719WA true SG11201707719WA (en) 2017-10-30

Family

ID=52686285

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201707719WA SG11201707719WA (en) 2015-03-20 2016-03-15 Dispersible dosage form

Country Status (16)

Country Link
US (1) US10617648B2 (en)
EP (2) EP3069713A1 (en)
JP (1) JP2018510162A (en)
KR (1) KR102119074B1 (en)
CN (1) CN107405308A (en)
AU (1) AU2016236390A1 (en)
BR (1) BR112017019927A2 (en)
CA (1) CA2978032C (en)
CO (1) CO2017009959A2 (en)
CR (1) CR20170427A (en)
MX (1) MX2017011774A (en)
PH (1) PH12017501546A1 (en)
RU (1) RU2733757C2 (en)
SG (1) SG11201707719WA (en)
TW (1) TW201641120A (en)
WO (1) WO2016150773A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3260114A1 (en) * 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
EP3260115A1 (en) * 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
EP3311665A1 (en) * 2016-10-21 2018-04-25 Omya International AG Use of surface-reacted calcium carbonate for preparing supersaturated aqueous systems
CN107255602B (en) * 2017-06-06 2020-05-05 武汉烽火锐拓科技有限公司 Method and device for on-line measuring density of loose body
WO2019006277A1 (en) * 2017-06-29 2019-01-03 Basf Se Water stable granules and tablets
JP6959669B2 (en) * 2017-07-27 2021-11-02 白石工業株式会社 Calcium carbonate, calcium carbonate preparations for food additives and foods
JP6719779B2 (en) * 2017-07-27 2020-07-08 白石工業株式会社 Foods containing calcium carbonate
TW202200206A (en) 2020-04-28 2022-01-01 瑞士商歐米亞國際公司 Granules comprising surface-reacted calcium carbonate as excipient

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5512411B2 (en) 1974-03-12 1980-04-02
US4451260A (en) 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
US4985459A (en) 1984-02-08 1991-01-15 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
JPS6143108A (en) 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd Medicinal drug and its preparation
PL149493B1 (en) 1985-04-12 1990-02-28 Method of obtaining a tablet capable to buoy over surface of gastric juice
US4627977A (en) 1985-09-13 1986-12-09 Colgate-Palmolive Company Anticalculus oral composition
GB8809421D0 (en) 1988-04-21 1988-05-25 Fordonal Sa Antacid compositions with prolonged gastric residence time
EP0717988B1 (en) 1993-08-20 2001-10-17 Nippon Shinyaku Company, Limited Gastric remaining preparation, swollen molding, and production process
US5939091A (en) * 1997-05-20 1999-08-17 Warner Lambert Company Method for making fast-melt tablets
FR2787802B1 (en) 1998-12-24 2001-02-02 Pluss Stauffer Ag NOVEL FILLER OR PIGMENT OR MINERAL TREATED FOR PAPER, ESPECIALLY PIGMENT CONTAINING NATURAL CACO3, METHOD FOR MANUFACTURING SAME, COMPOSITIONS CONTAINING THEM, AND APPLICATIONS THEREOF
US6582738B2 (en) 1999-09-13 2003-06-24 Deseret Laboratories, Inc. Process for preparing chewing gum containing a nutritional supplement
KR100610131B1 (en) 2000-09-06 2006-08-09 다나베 세이야꾸 가부시키가이샤 Preparations for oral administration
US20030157213A1 (en) 2002-02-19 2003-08-21 Jeffrey Jenkins Nutrient chewing gum
FR2852600B1 (en) 2003-03-18 2005-06-10 NEW MINERAL PIGMENT CONTAINING CALCIUM CARBONATE, AQUEOUS SUSPENSION CONTAINING SAME AND USES THEREOF
FR2871474B1 (en) 2004-06-11 2006-09-15 Omya Development Ag NEW DRY MINERAL PIGMENT CONTAINING CALCIUM CARBONATE, AQUEOUS SUSPENSION CONTAINING IT AND USES THEREOF
FR2881957B1 (en) 2005-02-16 2008-08-08 Solvay TABLETS COMPRISING A BIOLOGICALLY ACTIVE SUBSTANCE AND AN EXCIPIENT
FI20061146A0 (en) * 2006-11-10 2006-12-21 Iprbox Oy Grains, tablets and granulation method
ES2352298T3 (en) 2007-12-12 2011-02-17 Omya Development Ag PROCESS FOR PERFORMING PRECIPITATED CALCIUM CARBONATE TREATED SUPERFICIALLY.
EP2168572A1 (en) 2008-09-30 2010-03-31 Omya Development Ag New controlled release active agent carrier
DK2264109T3 (en) 2009-06-15 2012-05-21 Omya Development Ag Process for the preparation of surfactant calcium carbonate and its use
RS52297B (en) 2009-06-15 2012-12-31 Omya Development Ag Process to prepare a surface-reacted calcium carbonate implementing a weak acid
EP2515943A4 (en) * 2009-12-22 2014-04-30 Fmc Corp Microcrystalline cellulose and calcium carbonate compositions useful as recompactible pharmaceutical excipients
ES2550854T3 (en) 2012-06-28 2015-11-12 Omya International Ag Aqueous suspension with high solids content of pigments and / or filler material and / or minerals in an acidic pH environment
PT2719376E (en) * 2012-10-12 2015-07-06 Omya Int Ag Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate
DK2719373T3 (en) 2012-10-12 2017-07-03 Omya Int Ag Fast dissolving solid dosage formulation comprising functionalized calcium carbonate and process for the preparation thereof
EP2997833B1 (en) * 2014-09-22 2018-01-31 Omya International AG Surface-reacted calcium carbonate for use as anti-caking agent
EP3034070A1 (en) * 2014-12-18 2016-06-22 Omya International AG Method for the production of a pharmaceutical delivery system

Also Published As

Publication number Publication date
RU2733757C2 (en) 2020-10-06
MX2017011774A (en) 2017-12-04
PH12017501546A1 (en) 2018-02-05
CO2017009959A2 (en) 2018-01-05
RU2017134394A3 (en) 2019-04-03
CN107405308A (en) 2017-11-28
WO2016150773A1 (en) 2016-09-29
KR102119074B1 (en) 2020-06-05
CA2978032A1 (en) 2016-09-29
EP3270899A1 (en) 2018-01-24
AU2016236390A1 (en) 2017-11-09
TW201641120A (en) 2016-12-01
JP2018510162A (en) 2018-04-12
CR20170427A (en) 2018-04-02
KR20170129232A (en) 2017-11-24
US10617648B2 (en) 2020-04-14
RU2017134394A (en) 2019-04-03
BR112017019927A2 (en) 2018-06-12
US20180078506A1 (en) 2018-03-22
EP3069713A1 (en) 2016-09-21
CA2978032C (en) 2020-09-01

Similar Documents

Publication Publication Date Title
HK1243644A1 (en) Dispersible compositions
ZA201708081B (en) Preparation comprising arabinoxylo-oligosaccharides
SG11201707719WA (en) Dispersible dosage form
GB201515018D0 (en) Barrier
GB201514758D0 (en) Formulation
HK1231325A1 (en) Improved anti-vermin barrier
IL258243A (en) Barrier
SI3173071T1 (en) Maropitant formulation
GB201607548D0 (en) Solid dosage form
GB201521771D0 (en) Formulation
GB201511255D0 (en) Formulation
GB201509891D0 (en) Formulation
HRP20181406T1 (en) Pharmaceutical dosage forms
GB201500661D0 (en) Rake devices
IL242773A0 (en) Construction set
GB201514803D0 (en) Easy see mouse
GB201507279D0 (en) Odontalgic preparation
GB201514014D0 (en) Formulation
GB201508113D0 (en) Holdtrite mouse
GB201502709D0 (en) Barrier
GB201504662D0 (en) Formulation
GB201505126D0 (en) Concept four
GB201504142D0 (en) Option administration
AU2015003V (en) PencilGL Guichenotia macrantha